Price Chart: optinose.com (OPTN)

The market value dynamics on GURU.Markets show a current figure of 9.64 for OptiNose, Inc. (OPTN), which developed the innovative XHANCE drug delivery method for sinus treatment to combat polyps. The brand's monopoly status is secured by patents for the Xsail device and FDA approval. The team relies on experts in otolaryngology and marketing, creating a supportive environment for medical advancement.

OptiNose, Inc. - OPTN Price (period 07/04/2022 - 05/31/2025)

OptiNose Inc - analytical breakdowns and key metrics (OPTN)

- stock value and consensus price forecast:

Price Chart OptiNose, Inc.|OPTN - Average Forecast Price

- company stock exchange capitalization indicators:

Market Value OptiNose Inc|OPTN - Full Business Value

- balance sheet equity data:

Accounting Value per Share OptiNose|OPTN - Total Net Assets|Market Value to Book Value Ratio optinose.com|OPTN - Total Business Assets

- company total debt and liquidity indicators:

- financial results and valuation multiples details:

OPTN - Net Income|Projected Future Earnings OptiNose, Inc.|OPTN - P/E Multiple|Projected Price to Earnings OptiNose|OPTN - Growth-Adjusted Payback Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization OptiNose Inc|OPTN - Profit before interest, taxes and amortization|Net earnings per share for the last 12 months OptiNose|OPTN - Earnings per share for the last four quarters|Quarterly EPS earnings growth optinose.com|OPTN - Earnings per share increase in current year|Earnings growth forecast for next year OptiNose, Inc.

Fundamental valuation:OptiNose, Inc.

The price reflects the current market value of the asset, serving as an indicator of market confidence and a tool for assessing capital volatility. For OptiNose, Inc. (OPTN), the stock price chart reacts directly to XHANCE sales dynamics and insurance prescription approval rates, allowing investors to evaluate business resilience to regulatory risks in the nasal therapy sector through the depth of drawdowns.

Analysis of competing companies